James L. Boyer, Carol J. Soroka  Gastroenterology 

Slides:



Advertisements
Similar presentations
Alas! Ileal Interposition Surgery for Diabetes Prevention?
Advertisements

Volume 136, Issue 3, Pages e4 (March 2009)
Covering the Cover Gastroenterology
The FXR-FGF19 Gut–Liver Axis as a Novel “Hepatostat”
Volume 146, Issue 4, Pages (April 2014)
Julian R. F. Walters, Ali M. Tasleem, Omer S. Omer, W
Huiqin He, Zhinong Jiang, Leimin Sun  Gastroenterology 
Volume 152, Issue 4, Pages (March 2017)
Volume 146, Issue 4, Pages (April 2014)
An Unusual Cause of Lower Gastrointestinal Bleeding
Christoph Lübbert, Babett Holler  Gastroenterology 
Volume 142, Issue 7, Pages e6 (June 2012)
Covering the Cover Gastroenterology
Homing in on bile acid physiology
Volume 151, Issue 2, Pages (August 2016)
Gallstone Disease and Cancer Risk: Finding the Bug in the System
Outcomes Among Living Liver Donors
Ira J. Fox, Stephen C. Strom  Gastroenterology 
Gastroenterology 2011–2016: Looking Back and Forward
Biliary Obstruction From a Bile Duct Mass
Yi-An Pan, Ivy Yenwen Chau, Gar-Yang Chau  Gastroenterology 
Arun J. Sanyal, Veronica Miller  Gastroenterology 
Targeting the FXR Nuclear Receptor to Treat Liver Disease
Volume 134, Issue 5, Pages (May 2008)
Clinical Challenges and Images in GI
The Changing Liver Transplant Waitlist: An Emerging Liver Purgatory?
Unusual Case of an Upset Stomach
Ilya Gukovsky, Anna S. Gukovskaya  Gastroenterology 
Volume 135, Issue 4, Pages (October 2008)
A Historical Perspective on Clinical Advances in Pancreatic Diseases
Volume 150, Issue 4, Pages (April 2016)
Covering the Cover Gastroenterology
Colon Cancer: An Update and Future Directions
DCo(H2)ding the Metabolic Functions of SIRT1 in the Intestine
Singling Out Intestinal Epithelial Stem Cells
Ilya Gukovsky, Anna S. Gukovskaya  Gastroenterology 
Jinhan He, Shigeru Nishida, Meishu Xu, Makoto Makishima, Wen Xie 
Alas! Ileal Interposition Surgery for Diabetes Prevention?
An Unexpected Cause of Intestinal Obstruction in an Uncommon Site
Volume 17, Issue 6, Pages (June 2013)
Volume 7, Issue 1, Pages (April 2014)
Reduced Mortality Rates Following Elective Percutaneous Liver Biopsies
Volume 133, Issue 2, Pages (August 2007)
Volume 150, Issue 7, Pages (June 2016)
Ashwin N. Ananthakrishnan, David Lieberman  Gastroenterology 
Covering the Cover Gastroenterology
Volume 148, Issue 3, Pages (March 2015)
Covering the Cover Gastroenterology
Volume 150, Issue 7, Pages (June 2016)
Volume 136, Issue 7, Pages (June 2009)
The Rise and Fall (and Rise?) of Endoscopic Anti-Reflux Procedures
Covering the Cover Gastroenterology
The Dawning of a New Editorial Board for Gastroenterology
Hiroki Kitamoto, Tatsuki Kataoka, Shuji Yamamoto  Gastroenterology 
Volume 156, Issue 4, Pages (March 2019)
Changing of the Guards: 2011–2016 Gastroenterology Team
Would Free Fatty Acids Enhance Treatment of Obesity?
Volume 155, Issue 6, Pages (December 2018)
Volume 139, Issue 6, Pages e1 (December 2010)
Volume 138, Issue 6, Pages (May 2010)
End-Stage Liver Disease in 2008: Finally a Glass Half Full
Reinvesting in US Biomedical Research—The Time is Now
A Necrotic Liver Mass Gastroenterology
A Rare Primary Liver Tumor That Responded to Sorafenib
Electronic Clinical Challenges and Images in GI
Homing in on bile acid physiology
Controversies in Liver Transplantation for Hepatitis C
Volume 153, Issue 5, Pages (November 2017)
Volume 157, Issue 2, Pages (August 2019)
A Rare Tumor of the Liver With a Sudden Presentation
Presentation transcript:

A Cholecystohepatic Shunt Pathway: Does the Gallbladder Protect the Liver?  James L. Boyer, Carol J. Soroka  Gastroenterology  Volume 142, Issue 7, Pages 1416-1419 (June 2012) DOI: 10.1053/j.gastro.2012.04.036 Copyright © 2012 AGA Institute Terms and Conditions

Figure 1 Cholecystohepatic shunt in Cftr−/− mice. The absence of Cftr in the intestine (1) leads to the acidification of the intestinal lumen (2), which stimulates the production of the myorelaxant, vasointestinal peptide (3). Vasointestinal peptide circulates to the gallbladder (red line), resulting in delayed emptying of the gallbladder and, thus, reduced delivery of bile acids (Δ) to the duodenum (dotted green line) (4). This provides less bile acids for bacterial dehydroxylation to secondary bile acids (Δ), resulting in a more hydrophilic bile acid pool (5). In the ileum the decrease in intestinal bile acids down-regulates Asbt, Ostα-Ostβ, Fgf15, Shp, and Ibabp mRNA (6) and reduces the return of bile acids in the enterohepatic circulation (dotted green line) (7). In contrast, the more prolonged retention of bile acids in the gallbladder up-regulates Asbt, Ostα-Ostβ, and Fgf15 mRNA (8) and leads to an increased shunting of primary bile acids directly back to the liver (solid green line) (9). Gastroenterology 2012 142, 1416-1419DOI: (10.1053/j.gastro.2012.04.036) Copyright © 2012 AGA Institute Terms and Conditions